P. R. Galle, A. Forner, J. M. Llovet, V. Mazzaferro, F. Piscaglia et al., Clinical Practice Guidelines: Management of hepatocellular carcinoma, Journal of Hepatology, vol.69, pp.182-236, 2018.


A. Vogel, A. Cervantes, I. Chau, D. B. Llovet, J. M. Meyer et al., Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.29, pp.238-55, 2018.

V. Vilgrain, H. Pereira, E. Assenat, B. Guiu, A. D. Ilonca et al., Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial, The Lancet Oncology, vol.18, issue.17, pp.30683-30689, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01727346

P. Chow, M. Gandhi, S. Tan, M. W. Khin, A. Khasbazar et al., Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma, Journal of Clinical Oncology, vol.36, pp.1913-1934, 2018.

J. Ricke, H. J. Klümpen, H. Amthauer, I. Bargellini, P. Bartenstein et al., Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma, Journal of Hepatology, vol.71, pp.1164-74, 2019.


E. Garin, Y. Rolland, B. Campillo-gimenez, and E. J. , Negative phase 3 study of (90)Y microspheres versus sorafenib in HCC, Lancet Oncol, vol.19, issue.18, p.30024, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01709600

J. Edeline, L. Crouzet, B. Campillo-gimenez, Y. Rolland, M. Pracht et al.,

R. Salem, A. C. Gordon, S. Mouli, R. Hickey, J. Kallini et al., Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma, Gastroenterology, vol.151, pp.1155-1163, 2016.

M. Vouche, A. Habib, T. J. Ward, E. Kim, L. Kulik et al., Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy, Hepatology, vol.60, pp.192-201, 2014.


O. G. Olorunsola, M. P. Kohi, S. C. Behr, P. K. Kolli, A. G. Taylor et al., Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization, J Vasc Interv Radiol, vol.26, pp.1472-1480, 2015.

J. R. Kallini, A. Gabr, R. Hickey, L. Kulik, K. Desai et al., Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma, Cardiovasc Intervent Radiol, vol.40, pp.1213-1235, 2017.

S. Van-der-velden, M. Dietze, M. A. Viergever, and H. De-jong, Fast technetium-99m liver SPECT for evaluation of the pretreatment procedure for radioembolization dosimetry, Med Phys, vol.46, pp.345-55, 2019.

E. Garin, L. Lenoir, Y. Rolland, E. J. Mesbah, H. Laffont et al., Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results, J Nucl Med, vol.53, pp.255-63, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00866987

C. Chiesa, M. Mira, M. Maccauro, R. Romito, C. Spreafico et al., A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres, Q J Nucl Med Mol Imaging, vol.56, pp.503-511, 2012.

E. Garin, Y. Rolland, E. J. Icard, N. Lenoir, L. Laffont et al., Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis, J Nucl Med, vol.56, pp.339-385, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01128116

R. Salem, S. A. Padia, M. Lam, J. Bell, C. Chiesa et al., Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group, European Journal of Nuclear Medicine and Molecular Imaging, vol.46, pp.1695-704, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02152867


X. Palard, E. J. Rolland, Y. , L. Sourd, S. Pracht et al., Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma, Eur J Nucl Med Mol Imaging, vol.45, pp.392-401, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01709935